Medicine and the choice dilemma
Indian pharmaceuticals has evolved many folds in the past 3 decades and so has evolved the therapeutic approach of the healthcare industry with new discoveries, researches and experiments. New advancement has been made and further researches are still in progress to make the therapies even more compliant with minimum side effects. With a robust infrastructure with in the country only, the availability and supplies of the new and better therapies are not only available at every nook and corner of the country but also there is a huge export to almost the entire world. No doubt we Indians are known as ‘the pharmacy’ of the world.
But with so many therapies for a single disease and so many available options, It certainly gets confusing as to which is the best possible option for a particular type and demography of patient. Should a traditional but time tested therapy be used or a new, more promising but less used therapy can be more effective. The doctors and healthcare professionals always remain in dilemma as to what is the best possible option for a particular patient to be used so that the best possible results can be achieved. With a huge patient load on the doctors, there a huge time crunch on them to spare time to update themselves or to try new and diverse approaches. An established doctor who has spend more then 10 years in his practice after completing his study is still somewhat using the therapies which he was taught by his teachers a decade ago, whereas most likely, a numerous studies has happened in that disease and new and more promising therapies has evolved over time, which he either is not even aware of or not having enough information with him as to how they can be used.
Reverse to that is also true. Probably he attended some conferences and came to know about some benefits of a new therapy in a particular disease or disorder and has started using that on which, he is getting results also. But probably in many cases of the same disease or disorder, perhaps some older and well established therapies are a better approach due to either their safety profile or other variable compliances.
To tackle this problem and to make the doctors aware of the new therapies as well as about update on the established therapies, there are various modes exercised in the market like conferences, workshops or journals by associations like IMA or Medical colleges. But the most effective, wide spread and regular source among all the options is the Indian Pharmaceutical Industry which with their marketing force of MEDICAL REPRESENTATIVES makes sure that they reach the right doctor with the right therapy and the right knowledge to share with the doctor about what is the current best possible option to be chosen among available options in the market. The interactions are one to one and are continuous which makes this source most reliable one.
